|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.45 USD | +11.95% |
|
+16.65% | +25.73% |
| 07-31 | DexCom Shares Jump After Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised | MT |
| 07-31 | DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 31.49B | |||||
| 183B | |||||
| 109B | |||||
| 60.57B | |||||
| 51.8B | |||||
| 45.64B |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
